Go Pro
NYSE:HNGE

Hinge Health (HNGE) Stock Price, News & Analysis

Hinge Health logo
$95.11 +0.39 (+0.41%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$96.00 +0.89 (+0.93%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Hinge Health Stock (NYSE:HNGE)

Advanced

Key Stats

Today's Range
$92.60
$96.26
50-Day Range
$74.21
$95.11
52-Week Range
$30.08
$96.66
Volume
4.87 million shs
Average Volume
1.85 million shs
Market Capitalization
$7.67 billion
P/E Ratio
74.31
Dividend Yield
N/A
Price Target
$101.93
Consensus Rating
Moderate Buy

Company Overview

Hinge Health, Inc. is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.

Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians. The company also offers programs addressing areas such as chronic pain, joint health and pelvic health.

Hinge Health was founded in 2015 and primarily serves members through employer and health plan relationships in the United States. The company is led by co-founder and Chief Executive Officer Daniel Perez.

AI Generated. May Contain Errors.

Hinge Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

HNGE MarketRank™: 

Hinge Health scored higher than 63% of companies evaluated by MarketBeat, and ranked 264th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hinge Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 1 strong buy rating, 14 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for Hinge Health is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Hinge Health has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Hinge Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Hinge Health are expected to grow by 8.80% in the coming year, from $1.25 to $1.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hinge Health is 74.31, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hinge Health is 74.31, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.49.

  • Price to Book Value per Share Ratio

    Hinge Health has a P/B Ratio of 42.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    8.31% of the float of Hinge Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hinge Health has a short interest ratio ("days to cover") of 2.96, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hinge Health has recently decreased by 3.33%, indicating that investor sentiment is improving.
  • Dividend Yield

    Hinge Health does not currently pay a dividend.

  • Dividend Growth

    Hinge Health does not have a long track record of dividend growth.

  • News Sentiment

    Hinge Health has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Hinge Health this week, compared to 4 articles on an average week.
  • Search Interest

    14 people have searched for HNGE on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.
  • MarketBeat Follows

    Only 12 people have added Hinge Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hinge Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $335,841,156.00 in company stock.

  • Percentage Held by Insiders

    18.92% of the stock of Hinge Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Hinge Health has minimal institutional ownership at this time.

  • Read more about Hinge Health's insider trading history.
Receive HNGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hinge Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HNGE Stock News Headlines

The hidden costs of a hands-off retirement account
Contributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two different things. High fees, heavy company stock concentration, and target-date funds that follow a formula rather than your situation can quietly erode your balance over time. 74% of U.S. millionaires work with a financial advisor - more than double the general population rate. A fiduciary advisor can review your 401(k) for fees, allocation, and alignment with your actual timeline. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors in their area.tc pixel
$2M over asking on Hinge Health CEO’s Noe Valley home
Hinge Health (NYSE:HNGE) Chairman Sells 250,000 Shares of Stock
See More Headlines

HNGE Stock Analysis - Frequently Asked Questions

Hinge Health's stock was trading at $46.42 at the beginning of the year. Since then, HNGE stock has increased by 104.9% and is now trading at $95.1110.

Hinge Health Inc. (NYSE:HNGE) announced its quarterly earnings results on Tuesday, August, 4th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.31. The company's revenue was up 53.0% compared to the same quarter last year.
Read the conference call transcript
.

Hinge Health's board initiated a stock repurchase plan on Wednesday, November 12th 2025, which permits the company to buy back $250,000,000 in shares, according to EventVestor. This means that the company could purchase up to 7.2% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

Hinge Health (HNGE) raised $410 million in an initial public offering on Thursday, May 22nd 2025. The company issued 13,666,000 shares at $28.00-$32.00 per share.

Top institutional shareholders of Hinge Health include 11.2 Capital Management LLC (3.19%), Braidwell LP (1.65%), Wellington Management Group LLP (1.49%) and Assenagon Asset Management S.A. (0.11%). Insiders that own company stock include Bessemer Venture Partners X L, James Pursley, James Budge, Gabriel MI Mecklenburg, Daniel Antonio Perez, Kristina M Leslie and Insight Holdings Group, Llc.
View institutional ownership trends
.

Shares of HNGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/04/2026
Today
9/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:HNGE
Previous Symbol
NYSE:HNGE
CIK
1673743
Fax
N/A
Employees
1,437
Year Founded
2014

Price Target and Rating

High Price Target
$125.00
Low Price Target
$65.00
Potential Upside/Downside
+7.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.28
Trailing P/E Ratio
74.31
Forward P/E Ratio
76.09
P/E Growth
N/A
Net Income
-$528.26 million
Net Margins
15.15%
Pretax Margin
15.41%
Return on Equity
51.60%
Return on Assets
14.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.34
Quick Ratio
1.30

Sales & Book Value

Annual Sales
$587.86 million
Price / Sales
13.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.26 per share
Price / Book
42.08

Miscellaneous

Outstanding Shares
80,690,000
Free Float
65,427,000
Market Cap
$7.67 billion
Optionable
N/A
Beta
1.38

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NYSE:HNGE) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners